@welltopia: ONCE-WEEKLY INSULIN FOR PEDIATRIC TYPE 2 DIABETES The FDA has approved Awiqli—insulin icodec-abae—for patients ages 10 and older with type 2 diabetes. It is the first once-weekly insulin approved for this pediatric population. Weekly dosing may reduce the number of injections, but it also requires careful medication management. ⚠️ Once-weekly insulin is not interchangeable with daily insulin. Confusing the products, doses or injection schedules could cause severe hypoglycemia or an accidental overdose. Patients and caregivers should always: • Confirm the exact insulin name • Check the dose displayed on the pen • Use a clearly marked weekly schedule • Continue glucose monitoring as directed • Know the warning signs of low blood sugar This approval is for type 2 diabetes—not type 1 diabetes. No one should switch insulin products without instructions from the prescribing healthcare professional. Once-weekly insulin does not mean once-weekly attention to diabetes. 💊 Ask Omar the Pharmacist 🌐 welltopiarx.com 📞 262-429-9429 #WelltopiaPharmacy #AskOmarThePharmacist #DiabetesCare #InsulinSafety #Type2Diabetes
